Supplemental figures

Supplemental Figure 1 HSSY-II synovial sarcoma line SSX exon expression SW982 synovial sarcoma line SSX exon expression SYO-1 synovial sarcoma line SSX exon expression Supplemental Figure 1

Multi-plate, Multi-day Validation Supplemental Figure 2

Active Inactive Sarcoma Lines Compounds Tested Supplemental Figure 3

Supplemental Figure 4 hsa-miR-9-5p hsa-miR-22-3p hsa-miR-222-3p hsa-miR-125b-5p Supplemental Figure 4

D PI3K Akt mTOR Supplemental Figure 5

Supplemental Figure 6 hsa-miR-9-5p hsa-miR-100-5p hsa-miR-22-3p hsa-miR-30a-5p Supplemental Figure 6

NSC767128 Birinapant Supplemental Figure 7

A-204 cells Supplemental Figure 8

Supplemental Figure 9 Saracatinib NSC-758872 Astrazeneca ZM-336372 WZ-4002 NSC-755927 Dana-Farber Supplemental Figure 9